CHAPEL HILL, N.C.--(BUSINESS WIRE)--Jan. 20, 2005--POZEN, Inc.
(NASDAQ: POZN) announced today that John R. Plachetka, Pharm.D., the
company's chairman, president and chief executive officer, will be
speaking to investors at the Piper Jaffray Health Care Conference on
Thursday, January 27, 2005 at 3:30 p.m. Eastern Time in New York.
POZEN is a pharmaceutical company committed to developing
therapeutic advancements for diseases with unmet medical needs where
it can improve efficacy, safety, and/or patient convenience. Since its
inception, POZEN has focused its efforts primarily on the development
of pharmaceutical products for the treatment of migraine. POZEN is
also exploring the development of product candidates in other
pain-related therapeutic areas. POZEN has development and commercial
alliances with GlaxoSmithKline, Xcel Pharmaceuticals, and Nycomed. The
company's common stock is traded on The Nasdaq Stock Market under the
symbol "POZN". For detailed company information, including copies of
this and other press releases, see POZEN's website: www.pozen.com.
CONTACT: POZEN, Inc.
Fran Barsky 919-913-1044
SOURCE: POZEN, Inc.